Stock 2348 DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Dawnrays Pharmaceutical (Holdings) Limited

Equities

2348

KYG2687M1006

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
1.17 HKD 0.00% Intraday chart for Dawnrays Pharmaceutical (Holdings) Limited +1.74% +11.43%
Mar. 25 Dawnrays' 2023 Profit Falls 9% on Lower Revenue MT
Mar. 22 Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines. The products include intermediate pharmaceutical, bulk medicines and finished drugs. The Company operates its business through two segments. The Intermediates and Bulk Medicines segment is engaged in the manufacture and sale of intermediates and bulk medicines. The Finished Drugs segment is engaged in the manufacture and sale of finished drugs, including antibiotics finished drugs and non-antibiotics finished drugs.

Number of employees: 1,143

Sales per Business

HKD in Million2022Weight2023Weight Delta
Finished Drugs
88.8 %
1,322 89.0 % 1,129 88.8 % -14.63%
Intermediates and Bulk Medicines
11.2 %
163 11.0 % 143 11.2 % -12.43%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
98.5 %
1,417 95.4 % 1,254 98.5 % -11.55%
Other Countries
1.5 %
69 4.6 % 18 1.5 % -73.03%

Managers

Managers TitleAgeSince
Wei Xian Wu CEO
 Chief Executive Officer 55 22-02-15
Yi jun Wu DFI
 Director of Finance/CFO 59 02-11-30
Kei Ling Li CHM
 Chairman 75 02-09-30
Michelle Li IRC
 Investor Relations Contact - -
Kit Ling Pang SEC
 Corporate Secretary 58 03-06-30

Members of the board

Members of the board TitleAgeSince
Kei Ling Li CHM
 Chairman 75 02-09-30
Yung Lai Hung BRD
 Director/Board Member 79 02-09-30
Hong Man Leung BRD
 Director/Board Member 49 05-10-31
Hao Xi Ede BRD
 Director/Board Member 65 15-06-14
Tung Sing Lo BRD
 Director/Board Member 55 -
Ming Yee Lam BRD
 Director/Board Member 56 18-05-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,500,397,000 599,705,000 ( 39.97 %) 0 39.97 %

Shareholders

NameEquities%Valuation
Fortune United Group Ltd
39.78 %
596,932,000 39.78 % 89 M $
Toyo International Investment Ltd.
7.484 %
112,284,000 7.484 % 17 M $
Kei Ling Li
7.156 %
107,372,000 7.156 % 16 M $
Tung Ming Li
5.347 %
80,224,000 5.347 % 12 M $
UBS Asset Management (Hong Kong) Ltd.
2.469 %
37,044,000 2.469 % 6 M $
Leung Yiu Sing Family
0.2885 %
4,328,000 0.2885 % 646 993 $
CATAM Asset Management AG
0.2150 %
3,225,999 0.2150 % 482 255 $
Wei Xian Wu
0.1333 %
2,000,000 0.1333 % 298 980 $
Yung Lai Hung
0.1253 %
1,880,000 0.1253 % 281 041 $
Dimensional Fund Advisors Ltd.
0.0475 %
713,218 0.0475 % 106 619 $

Company contact information

Dawnrays Pharmaceutical Holdings Ltd.

Units 3001–02, 30/F, CNT Tower 338 Hennessy Road

, Hong Kong

+

http://www.dawnrays.com
address Dawnrays Pharmaceutical (Holdings) Limited(2348)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED Stock Dawnrays Pharmaceutical (Holdings) Limited
+11.43% 224M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 2348 Stock
  4. Company Dawnrays Pharmaceutical (Holdings) Limited